AMANTA Share Price | Amanta Healthcare Ltd Stock Analysis & Recommendation

Q: Should I buy, sell or hold Amanta Healthcar?

Based on the current analysis of Amanta Healthcare, it appears that selling the stock may be the most prudent decision at this time. The company has shown weak long-term fundamental strength, highlighted by a -2.00% compound annual growth rate (CAGR) in net sales over the past five years. Additionally, the high Debt to EBITDA ratio of 3.35 indicates a low ability to service its debt, which raises concerns about financial stability.While there are some attractive valuation metrics, such as a return on capital employed (ROCE) of 14 and an enterprise value to capital employed ratio of 1.8, the flat results reported in September and the lack of stock price appreciation over the past year (0.00% return) suggest that the company may not be in a strong position for growth.Considering these factors, it would be wise to consider selling your shares in Amanta Healthcare.

Q: Why is Amanta Healthcare Ltd falling/rising?

As of 07-Feb, Amanta Healthcare Ltd's stock price is falling, currently at 103.95, reflecting a decrease of 1.1 (-1.05%). The stock has underperformed its sector by 0.25% today and has been on a downward trend, having lost 3.75% over the last two days. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish sentiment among investors.Investor participation has also declined, with a delivery volume of 18.95k on February 5, which is down by 4.39% compared to the 5-day average. This reduction in trading activity suggests a lack of confidence among investors. Furthermore, the company has shown weak long-term fundamental strength, evidenced by a -2.00% compound annual growth rate (CAGR) in net sales over the past five years and a high debt to EBITDA ratio of 3.35 times, indicating a low ability to service debt.While the company has an attractive valuation with a return on capital employed (ROCE) of 14 and a significant profit increase of 189% over the past year, these positive factors are overshadowed by the weak sales growth and high debt levels. Overall, the combination of declining stock performance, reduced investor participation, and concerning financial metrics contributes to the current fall in Amanta Healthcare Ltd's stock price.

Upcoming Result: Amanta Healthcar will declare its result soon on 10 Feb 2026

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

6.27 k (-79.79%) Volume

Shareholding (Dec 2025)

FII

1.10%

Held by 6 FIIs

DII

7.20%

Held by 5 DIIs

Promoter

63.56%

Should I buy, sell or hold Amanta Healthcar?

22-Dec-2025

Why is Amanta Healthcare Ltd falling/rising?

07-Feb-2026

As of 07-Feb, Amanta Healthcare Ltd's stock price is declining, currently at 103.95, with a 1.1 (-1.05%) drop and underperformance against its sector. The stock's bearish trend is supported by weak investor participation and concerning financial metrics, including a negative CAGR in net sales and high debt levels.

View full answer

Which are the latest news on Amanta Healthcar?

08-Feb-2026

Amanta Healthcare Ltd is Rated Sell
Amanta Healthcar is Rated Sell by MarketsMOJO

Compare Amanta Healthcar with Similar Stocks

Solara Active PP Everest Organics Jenburkt Pharma

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Weak Long Term Fundamental Strength with a -2.00% CAGR growth in Net Sales over the last 5 years

Low ability to service debt as the company has a high Debt to EBITDA ratio of 3.35 times

Flat results in Sep 25

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

INR 403 Cr (Micro Cap)

P/E

38.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.40

Return on Equity

4.98%

Price to Book

1.94

Revenue and Profits:

Net Sales:

71 Cr

(Quarterly Results - Sep 2025)

Net Profit:

1 Cr

Total Returns

Total Returns (Price + Dividend)

Dividend Yield (0%)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-13.91%

6 Months

0.0%

1 Year

0.0%

2 Years

0.0%

3 Years

0.0%

4 Years

0.0%

5 Years

0.0%

Amanta Healthcar for the last several years.

Risk Adjusted Returns v/s

Returns Beta

Beta has not been calculated since enough price history is not available

News & Corporate Actions

News

Amanta Healthcare Ltd is Rated Sell

Amanta Healthcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 22 December 2025. However, the analysis and financial metrics discussed below reflect the stock's current position as of 03 February 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Amanta Healthcar is Rated Sell by MarketsMOJO

Amanta Healthcar is rated 'Sell' by MarketsMOJO, with this rating last updated on 22 December 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 23 January 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Amanta Healthcar is Rated Sell

Amanta Healthcar is rated 'Sell' by MarketsMOJO, with this rating last updated on 22 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Announcements

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

06-Feb-2026 | Source : BSE

Intimation of schedule of the Earnings conference call for Q3 and nine months of FY 2025-26

Intimation Of Opening Of Special Window For Transfer And Dematerialisation Of Physical Securities.

02-Feb-2026 | Source : BSE

Intimation of opening of special window for transfer and Dematerialisation of physical securities.

Board Meeting Intimation for To Approve Unaudited Financial Results For Quarter Ended December 31 2025.

02-Feb-2026 | Source : BSE

Amanta Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2026 inter alia to consider and approve To approve unaudited Financial Results for Quarter ended December 31 2025.

Corporate Actions

BOARD MEETING

10 Feb 2026

DIVIDEND

No Dividend history available

SPLITS

No Splits history available

BONUS

No Bonus history available

RIGHTS

No Rights history available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

-2.00%

EBIT Growth (5y)

9.30%

EBIT to Interest (avg)

1.30

Debt to EBITDA (avg)

3.27

Net Debt to Equity (avg)

1.99

Sales to Capital Employed (avg)

0.80

Tax Ratio

28.62%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

12.34%

ROCE (avg)

13.97%

ROE (avg)

8.18%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.92

EV to EBIT

11.80

EV to EBITDA

8.16

EV to Capital Employed

1.66

EV to Sales

1.77

PEG Ratio

Dividend Yield

ROCE (Latest)

14.03%

ROE (Latest)

4.98%

Technicals key factors

Indicator

Weekly

Monthly

No records

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Dec 2025

Shareholding Compare (%holding)

Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 1 Schemes (3.99%)

FIIs

Held by 6 FIIs (1.1%)

Promoter with highest holding

Bhavesh Girishbhai Patel (16.1%)

Highest Public shareholder

Bandhan Small Cap Fund (3.99%)

Individual Investors Holdings

16.91%

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Sep'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 8.54% vs -9.37% in Jun 2025",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is -65.53% vs -41.11% in Jun 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "70.89",
          "val2": "65.31",
          "chgp": "8.54%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "14.65",
          "val2": "14.90",
          "chgp": "-1.68%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "5.15",
          "val2": "6.29",
          "chgp": "-18.12%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2.63",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "1.21",
          "val2": "3.51",
          "chgp": "-65.53%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "20.67%",
          "val2": "22.81%",
          "chgp": "-2.14%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "136.19",
          "val2": "134.83",
          "chgp": "1.01%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "29.54",
          "val2": "27.28",
          "chgp": "8.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "11.44",
          "val2": "15.77",
          "chgp": "-27.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2.63",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "4.71",
          "val2": "1.90",
          "chgp": "147.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "21.69%",
          "val2": "20.23%",
          "chgp": "1.46%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "206.89",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "46.24",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "22.05",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "7.86",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "22.35%",
          "val2": "NA%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "274.71",
          "val2": "280.34",
          "chgp": "-2.01%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "59.67",
          "val2": "57.49",
          "chgp": "3.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "27.95",
          "val2": "33.64",
          "chgp": "-16.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "10.50",
          "val2": "3.63",
          "chgp": "189.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "21.72%",
          "val2": "20.51%",
          "chgp": "1.21%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Sep'25 - QoQ

Sep'25

Jun'25

Change(%)

Net Sales

70.89

65.31

8.54%

Operating Profit (PBDIT) excl Other Income

14.65

14.90

-1.68%

Interest

5.15

6.29

-18.12%

Exceptional Items

-2.63

0.00

Standalone Net Profit

1.21

3.51

-65.53%

Operating Profit Margin (Excl OI)

20.67%

22.81%

-2.14%

Values in Rs Cr.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Sep 2025 is 8.54% vs -9.37% in Jun 2025

Standalone Net Profit

QoQ Growth in quarter ended Sep 2025 is -65.53% vs -41.11% in Jun 2025

All Quarterly Results

Half Yearly Results Snapshot (Standalone) - Sep'25

Sep'25

Sep'24

Change(%)

Net Sales

136.19

134.83

1.01%

Operating Profit (PBDIT) excl Other Income

29.54

27.28

8.28%

Interest

11.44

15.77

-27.46%

Exceptional Items

-2.63

0.00

Standalone Net Profit

4.71

1.90

147.89%

Operating Profit Margin (Excl OI)

21.69%

20.23%

1.46%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Half Yearly Results

Nine Monthly Results Snapshot (Standalone) - Mar'25

Mar'25

Change(%)

Net Sales

206.89

Operating Profit (PBDIT) excl Other Income

46.24

Interest

22.05

Exceptional Items

0.00

Standalone Net Profit

7.86

Operating Profit Margin (Excl OI)

22.35%

NA%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Nine Monthly Results

Annual Results Snapshot (Standalone) - Mar'25

Mar'25

Mar'24

Change(%)

Net Sales

274.71

280.34

-2.01%

Operating Profit (PBDIT) excl Other Income

59.67

57.49

3.79%

Interest

27.95

33.64

-16.91%

Exceptional Items

0.00

Standalone Net Profit

10.50

3.63

189.26%

Operating Profit Margin (Excl OI)

21.72%

20.51%

1.21%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Annual Results

Company CV

About Amanta Healthcare Ltd

Amanta Healthcare Ltd

Micro Cap

Pharmaceuticals & Biotechnology

Amanta Healthcare Limited was originally incorporated on December 21, 1994 as Marck Parenterals (India) Limited with RoC, Gujarat, at Ahmedabad by converting the existing Partnership Firm "Marck Parenterals (India)" on January 06, 1995. The Company name was changed to "Marck Biosciences Limited" vide a fresh Certificate of Incorporation issued by the Registrar of Companies, Gujarat, at Ahmedabad, dated November 2, 2005 and was again changed to "Amanta Healthcare Limited" dated June 24, 2014.

Company Coordinates

No Company Details Available

Amanta Healthcar

1Day

52 Week

CASH

FII

DII

Promoter

Should I buy, sell or hold Amanta Healthcar?

Watch in Real-Time

Why is Amanta Healthcare Ltd falling/rising?

Which are the latest news on Amanta Healthcar?

Compare Amanta Healthcar with Similar Stocks

MarketsMojo — Loved in India, Now Global

Dashboard

Weak Long Term Fundamental Strength with a -2.00% CAGR growth in Net Sales over the last 5 years

Flat results in Sep 25

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

Returns Beta

News

Amanta Healthcare Ltd is Rated Sell

Amanta Healthcar is Rated Sell by MarketsMOJO

Amanta Healthcar is Rated Sell

Announcements

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Intimation Of Opening Of Special Window For Transfer And Dematerialisation Of Physical Securities.

Board Meeting Intimation for To Approve Unaudited Financial Results For Quarter Ended December 31 2025.

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Dec 2025

Shareholding Compare (%holding)

Quarterly Results Snapshot (Standalone) - Sep'25 - QoQ

Half Yearly Results Snapshot (Standalone) - Sep'25

Nine Monthly Results Snapshot (Standalone) - Mar'25

Annual Results Snapshot (Standalone) - Mar'25

About Amanta Healthcare Ltd

Company Coordinates